"Drugs don’t work in patients who don’t take them."- C. Everett Koop, Former US Surgeon General
According to the WHO, chronic disease prevalence is expected to rise to 57% of the world’s population by 2020.
Optimization of medication adherence is estimated to provide an opportunity for $290 billion in savings in the US alone (New England Healthcare Institute, CPESN, 2017).
Approximately 50% of patients with chronic conditions in developed countries do not adhere to their medication regimen (WHO).
Medication Adherence refers to whether patients take their medications as prescribed, or the correspondence between drug administration and the actual history of the prescribed regimen.
Blue Charm Adherence will commence a launch to its industry partners in the first quarter of 2021. The medication adherence platform will then be available directly to patients in the second quarter of 2021. We are now encouraging healthcare providers and pharmaceutical brands to come together and work with us on this important initiative and tools for improvements to medication adherence.